SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 10, 2002
ENZON PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12957 22-2372868
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
685 Route 202/206, Bridgewater, New Jersey 08807
(Address of principal executive offices) (Zip Code)
(Registrant's telephone number, including area code: (908) 541-8600
ENZON, INC.
(Former name or former address, if changed since last report)
Item 5. Other Events
Attached hereto as Exhibit A is the Certificate of Amendment of the
Certificate of Incorporation of Enzon Pharmaceuticals, Inc. (the "Company") as
filed with the state of Delaware on December 10, 2002. The amendment changes the
Company's name from "Enzon, Inc." to "Enzon Pharmaceuticals, Inc."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: December 10, 2002
By: /s/ Kenneth J. Zuerblis
-------------------------
Kenneth J. Zuerblis
Vice President, Finance and
Chief Financial Officer
EXHIBIT A
CERTIFICATE OF AMENDMENT
OF
CERTIFICATE OF INCORPORATION
OF ENZON, INC.
Enzon, Inc., a corporation organized and existing under and by virtue of
the General Corporation Law of the State of Delaware (the "Corporation"), DOES
HEREBY CERTIFY:
FIRST: That at a meeting of the Board of Directors of the Corporation
resolutions were duly adopted setting forth a proposed amendment of the
Certificate of Incorporation of the Corporation to change the name of the
Corporation from "Enzon, Inc." to "Enzon Pharmaceuticals, Inc.", declaring said
amendment to be advisable and directing that said amendment be considered at the
next annual meeting of the stockholders.
SECOND: That thereafter, pursuant to resolution of its Board of Directors,
the annual meeting of the stockholders of the Corporation was duly called and
held, upon notice in accordance with Section 222 of the General Corporation Law
of the State of Delaware at which meeting the necessary number of shares
required by statute were voted in favor of the following amendment:
"The Certificate of Incorporation of Enzon, Inc. shall be amended by
deleting Article 1 thereof and fully restating it as follows:
Article 1: The name of the corporation is Enzon Pharmaceuticals,
Inc. (the "Corporation")."
THIRD: That said amendment was duly adopted in accordance with the
applicable provisions of Section 242 of the General Corporation Law of the State
of Delaware.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of
Amendment on behalf of the Corporation this 10th day of December 2002.
/s/ Arthur J. Higgins
--------------------------------
By: Arthur J. Higgins
Title: President, Chief Executive Officer